1. Home
  2. BHVN vs OGN Comparison

BHVN vs OGN Comparison

Compare BHVN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.39

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.39

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
OGN
Founded
2013
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
BHVN
OGN
Price
$11.39
$13.39
Analyst Decision
Buy
Hold
Analyst Count
14
5
Target Price
$29.08
$11.40
AVG Volume (30 Days)
1.7M
7.2M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
26.08
N/A
EPS
N/A
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$24.37
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$5.69
52 Week High
$18.57
$13.48

Technical Indicators

Market Signals
Indicator
BHVN
OGN
Relative Strength Index (RSI) 68.12 75.57
Support Level $10.75 $10.05
Resistance Level $11.92 $13.44
Average True Range (ATR) 0.66 0.06
MACD 0.20 -0.22
Stochastic Oscillator 99.48 52.50

Price Performance

Historical Comparison
BHVN
OGN

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: